According to a report from the American Heart Association over 92 million US adults have at least one type of cardiovascular disease (CVD). Technological advancements have been adopted in cardiac care to assist in CVD therapy for better outcomes. The objective of this paper is to review major applications of technological advances in cardiac care including robot-assisted heart surgery, implantable cardiac technologies, and heart valve replacement, and highlight the associated benefits. Robot-assisted cardiac surgery (RACS) is an innovative procedure that allows surgeons to operate through small incisions in the chest instead of opening the chest cavity. Atrial fibrillation correction, removal of heart tumors, and dysfunctional heart valve repair are some applications of RACS. RACS has become popular due to its increased precision and improved safety when compared with conventional cardiac surgical procedures. Implantable technologies, such as the leadless pacemaker, Implantable Cardioverter Defibrillator, and Ventricular Assist Device have enhanced patient care by providing improved, long-term therapeutic cardiac solutions. The use of 3D-bioprinting and transcatheter valve replacement have provided major innovations in cardiac surgery. Through the integration of advanced technologies, medical procedures and devices have become more safe, efficient, and cost-effective. Future refinements and innovations based on multidisciplinary collaborations will be essential for continued adoption by clinicians for CVD management. In conclusion, technological advances applied in cardiac health care can provide doctors with the ability to improve patient care and ease of access, thus proving to be beneficial to all the stakeholders in the healthcare delivery spectrum.
No takes yet. Share an insight, caveat, or question.
Norve et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: